C. Le Roux‐Villet

595 total citations
20 papers, 280 citations indexed

About

C. Le Roux‐Villet is a scholar working on Pathology and Forensic Medicine, Genetics and Rheumatology. According to data from OpenAlex, C. Le Roux‐Villet has authored 20 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 14 papers in Genetics and 13 papers in Rheumatology. Recurrent topics in C. Le Roux‐Villet's work include Autoimmune Bullous Skin Diseases (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Urticaria and Related Conditions (13 papers). C. Le Roux‐Villet is often cited by papers focused on Autoimmune Bullous Skin Diseases (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Urticaria and Related Conditions (13 papers). C. Le Roux‐Villet collaborates with scholars based in France, Belgium and Norway. C. Le Roux‐Villet's co-authors include C. Prost‐Squarcioni, F. Caux, M. Alexandre, L. Laroche, Serge Doan, Françoise Aucouturier, N. Lièvre, Francis Pascal, Marie-Dominique Brette and H. Bachelez and has published in prestigious journals such as Frontiers in Immunology, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

C. Le Roux‐Villet

18 papers receiving 275 citations

Peers

C. Le Roux‐Villet
Rocco della Torre Switzerland
C. Le Roux‐Villet
Citations per year, relative to C. Le Roux‐Villet C. Le Roux‐Villet (= 1×) peers Rocco della Torre

Countries citing papers authored by C. Le Roux‐Villet

Since Specialization
Citations

This map shows the geographic impact of C. Le Roux‐Villet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Le Roux‐Villet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Le Roux‐Villet more than expected).

Fields of papers citing papers by C. Le Roux‐Villet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Le Roux‐Villet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Le Roux‐Villet. The network helps show where C. Le Roux‐Villet may publish in the future.

Co-authorship network of co-authors of C. Le Roux‐Villet

This figure shows the co-authorship network connecting the top 25 collaborators of C. Le Roux‐Villet. A scholar is included among the top collaborators of C. Le Roux‐Villet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Le Roux‐Villet. C. Le Roux‐Villet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bohelay, G., M. Alexandre, Antoine Martin, et al.. (2024). Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review. Frontiers in Immunology. 15. 1243566–1243566.
2.
Bohelay, G., M. Alexandre, Joël Cucherousset, et al.. (2024). Activity of apremilast in a patient with severe pemphigus vulgaris: case report. Frontiers in Immunology. 15. 1404185–1404185. 6 indexed citations
3.
Bohelay, G., M. Alexandre, C. Le Roux‐Villet, et al.. (2022). Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients. Frontiers in Immunology. 13. 915205–915205. 9 indexed citations
4.
Alexandre, M., G. Bohelay, Thomas Gille, et al.. (2022). Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients. Frontiers in Immunology. 13. 874108–874108. 11 indexed citations
5.
Bohelay, G., Thomas Gille, C. Le Roux‐Villet, et al.. (2022). Bronchial involvement in mucous membrane pemphigoid: 2 cases and a literature review. Annales de Dermatologie et de Vénéréologie. 150(1). 64–70. 2 indexed citations
6.
Roux‐Villet, C. Le, et al.. (2021). Les soins locaux dans la pemphigoïde bulleuse. 2(1). 62–66. 1 indexed citations
7.
Staumont‐Sallé, D., S. Oro, N. Dupin, et al.. (2020). Efficacité du rituximab dans les maladies à IgA linéaire : une cohorte rétrospective. Annales de Dermatologie et de Vénéréologie. 147(12). A74–A74.
8.
Yatim, Ahmad, G. Bohelay, S. Grootenboer‐Mignot, et al.. (2019). Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa. Frontiers in Medicine. 6. 249–249. 19 indexed citations
9.
Zehou, O., C. Le Roux‐Villet, M. Alexandre, et al.. (2017). Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid. British Journal of Dermatology. 177(4). 1074–1085. 18 indexed citations
10.
Aucouturier, Françoise, C. Le Roux‐Villet, Valérie Pendaries, et al.. (2016). Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA). Journal of the American Academy of Dermatology. 74(6). 1166–1172. 21 indexed citations
11.
Roux‐Villet, C. Le, Serge Doan, M. Alexandre, et al.. (2012). Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid. British Journal of Dermatology. 168(2). 381–390. 37 indexed citations
12.
Roux‐Villet, C. Le, Pascale Loiseau, Marc Busson, et al.. (2011). Black Patients of African Descent and HLA-DRB1*15:03 Frequency Overrepresented in Epidermolysis Bullosa Acquisita. Journal of Investigative Dermatology. 131(12). 2386–2393. 57 indexed citations
13.
Roux‐Villet, C. Le, C. Prost‐Squarcioni, M. Alexandre, et al.. (2011). Rituximab for Patients With Refractory Mucous Membrane Pemphigoid. Archives of Dermatology. 147(7). 843–843. 80 indexed citations
14.
Roux‐Villet, C. Le & C. Prost‐Squarcioni. (2011). L’épidermolyse bulleuse acquise : revue de la littérature. Annales de Dermatologie et de Vénéréologie. 138(3). 228–246. 5 indexed citations
15.
Roux‐Villet, C. Le, et al.. (2010). Rôle infirmier dans la prise en charge de la pemphigoïde bulleuse. La Revue de l Infirmière. 38–40. 2 indexed citations
16.
Oro, S., J C Roujeau, V. Ferranti, C. Le Roux‐Villet, & P. Joly. (2009). Facteurs associés au retard diagnostique dans la pemphigoïde bulleuse. Annales de Dermatologie et de Vénéréologie. 136(10). 696–701. 1 indexed citations
17.
Roux‐Villet, C. Le, et al.. (2008). Érythème annulaire récidivant après angine streptococcique : érythème marginé rhumatismal de l’adulte. Annales de Dermatologie et de Vénéréologie. 135(6-7). 496–498. 1 indexed citations
18.
Doan, Serge, et al.. (2006). Rituximab in Severe Ocular Cicatricial Pemphigoid. Investigative Ophthalmology & Visual Science. 47(13). 594–594. 1 indexed citations
19.
Roux‐Villet, C. Le, C. Prost‐Squarcioni, Marie-Dominique Brette, et al.. (2005). C14 - Traitement des formes réfractaires de pemphigoïdes des muqueuses par le rituximab (anticorps anti-cd20). Annales de Dermatologie et de Vénéréologie. 132. 9–10. 3 indexed citations
20.
Roux‐Villet, C. Le, C. Prost‐Squarcioni, B. Sassolas, et al.. (2004). IgM bullous disease associated with IgM gammopathy: a report of two cases and review. British Journal of Dermatology. 150(2). 392–394. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026